BENZOYL PEROXIDE
-
benzoyl peroxide cream
River's Edge Pharmaceuticals, LLC
----------
RE Benzoyl Peroxide Cream 3.5%RE Benzoyl Peroxide Cream is a topical preparation containing benzoyl peroxide as the active ingredient incorporated into a series of microscopic concentric vesicules of oil and water. This system results in the release of the active ingredient being released into the skin over a sustained period of time.
Benzoyl peroxide 3.5%, 5.5%, and 8.5%, respectively.
Cetyl Alcohol, Laureth-7, C13-14 Isoparaffin, Cetearyl Alcohol (and) PEG-3 Distearoylamidoethylmonium Methosulfate (and) Polysorbate 60, Ethylhexyl Palmitate, Glyceryl Dilaurate, Stearyl Alcohol, Methylparaben, Propylparaben, Purified Water, Magnesium Aluminum Silicate, Silica, Sorbitol Solution, Sodium Lauryl Sulfate, Xanthan Gum, Polyacrylamide, Glycerin, Citric Acid, Sodium Citrate.
The exact method of action of benzoyl peroxide in acne vulgaris is not known. Benzoyl peroxide is an antibacterial agent with demonstrated activity against Propionibacterium acnes. This action, combined with the mild keratolytic effect of benzoyl peroxide is believed to be responsible for its usefulness in acne. Benzoyl peroxide is absorbed by the skin where it is metabolized to benzoic acid and excreted as benzoate in the urine.
RE Benzoyl Peroxide Cream is indicated for use in the topical treatment of mild to moderate acne vulgaris.
RE Benzoyl Peroxide Cream should not be used in patients who have shown hypersensitivity to benzoyl peroxide or to any of the other ingredients in the products.
When using this product, avoid unnecessary sun exposure and use a sunscreen.
General: For external use only. Avoid contact with eyes and mucous membranes. If severe irritation develops, discontinue use and seek appropriate therapy.
Information for Patients: Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water.
AVOID CONTACT WITH HAIR, FABRICS OR CARPETING AS BENZOYL PEROXIDE WILL CAUSE BLEACHING OR DISCOLORATION.
If excessive irritation develops, discontinue use and consult your physician.
Benzoyl peroxide is not considered to be a carcinogen based upon all available evidence. Data from a study using mice known to be highly susceptible to cancer suggest that benzoyl peroxide may act as a tumor promoter. The clinical significance of the findings is not known.
Category C - Animal reproduction studies have not been conducted with benzoyl peroxide. It is also not known whether benzoyl peroxide can cause fetal harm when administered to pregnant women or can affect fertility. Benzoyl peroxide should be used by pregnant women only if clearly needed.
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when benzoyl peroxide is administered to nursing women.
Safety and effectiveness in children below the age of 12 have not been established.
Allergic contact dermatitis and dryness have been reported with topical benzoyl peroxide therapy.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
If excessive scaling, erythema or edema occurs, the use of these preparations should be discontinued. Cool compresses may be used to hasten resolution of the adverse effects. After symptoms and signs subside, a reduced dosage schedule may be cautiously tried if the reaction is judged to be due to excessive use and not allergenicity.
RE Benzoyl Peroxide Cream should be applied once or twice daily to the affected area. To achieve desired results, frequency can be adjusted. Gently cleanse the affected areas prior to application. By the third week of therapy, clinically visible improvement will normally occur. After approximately eight to twelve weeks of use, maximum lesion reduction may be expected. Maintain a satisfactory clinical response by continuing use of the drug as advised by your physician.
RE Benzoyl Peroxide Cream is supplied in 45 gram tubes, as:
RE Benzoyl Peroxide Cream 3.5%, NDC # 68032-289-45
RE Benzoyl Peroxide Cream 5.5%, NDC # 68032-290-45
RE Benzoyl Peroxide Cream 8.5%, NDC # 68032-291-45.
Store between 15-30°C (59-86°F).
BENZOYL PEROXIDE
benzoyl peroxide cream |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved drug other | 11/14/2008 | 02/28/2012 |
Labeler - River's Edge Pharmaceuticals, LLC (133879135) |